Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Oman.
Campus
Campus

Every Exacerbation Counts

AECOPD_slide_1
AECOPD_slide_2
AECOPD_slide_3
AECOPD_slide_4
AECOPD_slide_5

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2026. Accessed February 3, 2026. https://goldcopd.org/2026-gold-report-and-pocket-guide/
  2. Whittaker H, et al. Int J Chron Obstruct Pulmon Dis. 2022;17:427-437.
  3. Halpin DMG, et al. Respir Med. 2017;128:85-91.
  4. Rothnie KJ, et al. Am J Respir Crit Care Med. 2018;198:464-471.
  5. Hurst JR, et al. Eur J Intern Med. 2020;73:1-6.
  6. Santibáñez M, et al. PLoS One. 2016;11(6):e0158727.
  7. Couillard S, et al. Chest. 2017;151(2):366-373.
  8. Chen F, et al. PLoS One. 2024;19(10):e0302318.
  9. Yun JH, et al. J Allergy Clin Immunol. 2018;141(6):2037-2047.e10.
  10. Bélanger M, et al. Int J Chron Obstruct Pulmon Dis. 2018;13:3045-3054.
  11. Kunisaki KM, et al. Am J Respir Crit Care Med. 2018;198(1):51-57.
  12. Løkke A, et al. Int J Chron Obstruct Pulmon Dis. 2022;17:569-578.
  13. Rhodes K, et al. BMJ Open. 2025;15(7):e097006.
Related articles
Lung Function in COPD

Lung Function in COPD

Read article
Blood Eosinophils: A Biomarker in COPD

Blood Eosinophils: A Biomarker in COPD

Read article
Dupilumab Efficacy Across Baseline Eosinophil Counts in COPD

Dupilumab Efficacy Across Baseline Eosinophil Counts in COPD

Dupilumab Efficacy in COPD Patients with Type 2 Inflammation: Post Hoc Analysis Stratified by Baseline
Blood Eosinophil Counts (≥150 vs ≥300 cells/μL) from Pooled BOREAS and NOTUS Data

Read article
MAT-BH-2600524-1.0-09/2026